Copyright
©The Author(s) 2023.
World J Psychiatry. Mar 19, 2023; 13(3): 84-112
Published online Mar 19, 2023. doi: 10.5498/wjp.v13.i3.84
Published online Mar 19, 2023. doi: 10.5498/wjp.v13.i3.84
Table 5 Overlapping symptoms between attention-deficit/hyperactivity disorder, substance use/substance use disorder and other psychiatric disorders
Symptom | ADHD | SU/SUD | Other psychiatric comorbidity1 |
Agitation | √ | √ | √ |
Anxiety | √ | √ | √ |
Hyperactivity | √ | √ | |
Impulsivity | √ | √ | √ |
Inattention | √ | √ | √ |
Intolerance to frustrations | √ | √ | √ |
Mood instability | √ | √ | √ |
Poor concentration | √ | √ | √ |
Poor memory | √ | √ | √ |
Restlessness | √ | √ | √ |
Risk-taking behavior | √ | √ | √ |
Sleep difficulties | √ | √ |
- Citation: Young S, Abbasian C, Al-Attar Z, Branney P, Colley B, Cortese S, Cubbin S, Deeley Q, Gudjonsson GH, Hill P, Hollingdale J, Jenden S, Johnson J, Judge D, Lewis A, Mason P, Mukherjee R, Nutt D, Roberts J, Robinson F, Woodhouse E, Cocallis K. Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement. World J Psychiatry 2023; 13(3): 84-112
- URL: https://www.wjgnet.com/2220-3206/full/v13/i3/84.htm
- DOI: https://dx.doi.org/10.5498/wjp.v13.i3.84